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Background: Evaluation of automated attenuation-based tube potential selection and its impact on image quality
and radiation dose in CT (computed tomography) examinations for cancer staging.
Methods: A total of 110 (59 men, 51 women) patients underwent chest-abdomen-pelvis CT examinations; 55
using a fixed tube potential of 120 kV/current of 210 Reference mAs (using CareDose4D), and 55 using automated
attenuation-based tube potential selection (CAREkV) also using a current of 210 Reference mAs.
This evaluation was performed as a single-centre, observer-blinded retrospective analysis. Image quality was
assessed by two readers in consensus. Attenuation, image noise, signal-to-noise ratio (SNR), and contrast-to-noise
ratio (CNR) were measured or calculated for objective image evaluation. For the evaluation of radiation exposure,
dose-length-product (DLP) values were compared and Size-specific dose estimates (SSDE) values were calculated.
Results: Diagnostic image quality was obtained from all patients. The median DLP (703.5 mGy · cm, range 390–2203
mGy · cm) was 7.9% lower when using the algorithm compared with the standard 120 kV protocol (median 756 mGy ·
cm, range 345–2267 mGy · cm). A reduction in potential to 100 kV occurred in 32 cases; therefore, these patients
received significantly lower radiation exposure compared with the 120 kV protocol.
Conclusion: Automated attenuation-based tube potential selection produces good diagnostic image quality in
chest-abdomen-pelvis CT and reduces the patient’s overall radiation dose by 7.9% compared to the standard
120 kV protocol.
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In the clinic, the number of computed tomography (CT)
examinations is increasing steadily [1,2]. Compared with
most other imaging modalities, CT imaging involves the
use of increased radiation exposure [3]. In CT examina-
tions as well as in all other examination modalities, the
‘as low as reasonably achievable’ (ALARA) rule has to be
considered, especially when radiation is applied to the
patient. However, not only are the number of CT exami-
nations increasing, the examination volume (e.g. chest-* Correspondence: beeres@gmx.net
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unless otherwise stated.abdomen-pelvis examination) is increasing, too [3]. In
terms of staging cancer, the patient’s cumulative radi-
ation exposure might cause problems in the future [3].
In some cases, cancer is already the limiting disease, and
therefore the benefits of staging cancer using radiation
exposure outweigh the risks [4]. However, some cancer
patients—especially those in the early stages—will live
long enough that the long-term effects of radiation be-
come significant [5]. Many techniques are already in use
to minimise the radiation exposure of CT examinations:
Automated attenuation-based tube current and voltage
modulation as well as noise reduction filters and itera-
tive reconstruction algorithms are current options [6,7].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Study population and examination parameters
Group 1 Group 2
Imaging mode Single-source Single-source
Slice · collimation (mm) 128 · 0.6 128 · 0.6
Pitch 1.2 1.2
kV/ref.mAs 120/210 (CarekV) 120/210 (CareDose4D)
Patients 100 kV 32
Patients 120 kV 17 55
Patients 140 kV 6
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tube current was introduced, it has been used routinely
all over the world and remains an important invention
for reducing the radiation dose from imaging techniques
[6,8–11]. Automated X-ray tube potential selection is
also providing clinical radiologists and technicians an-
other opportunity to adapt the radiation dose of the CT
examination to the requirements of the specific body re-
gion [12–16].
The rationale behind automated tube potential selec-
tion is that the contrast can be improved using lower X-
ray tube potential, because low-energy X-rays are better
absorbed than high-energy X-rays [17]. For larger pa-
tients, the tube potential sometimes has to be adjusted
to higher levels due to increased absorption occurring at
a low tube potential [17].
Since automated attenuation-based tube potential se-
lection was introduced in 2011, the technique has helped
to lower radiation exposure, presumably as well as the
automated tube current modulation has done, and con-
tinues to do so [14]. A limited number of studies have
investigated radiation exposure while using automated
tube potential selection [12–16,18]. One of the first trials
reported using automated tube potential selection was
performed for the imaging of the great vessels; in this
case, it was possible to lower radiation exposure by
25.1% [18]. This may be too much of a reduction for
chest-abdomen-pelvic CT examinations, so the aim of
our study was to evaluate automated tube potential se-
lection for chest-abdomen-pelvic CT examinations car-
ried out for staging reasons in cancer patients.
Methods
Patients
The study was performed as a single-centre, observer-
blind study. The Institutional Review Board of our Univer-
sity Clinic (Goethe University Clinic, Frankfurt, Germany)
approved this study; written informed consent require-
ment was waived since CAREkV is routinely used in all
patients undergoing clinically indicated CT in our depart-
ment. The data from consecutive unselected patients who
underwent clinically indicated chest-abdomen-pelvis sta-
ging CT between January 2011 and March 2012 were ana-
lysed. The general exclusion criteria for contrast-enhanced
CT included impaired renal function (estimated glomeru-
lar filtration rate <60 mL/min, calculated by creatinine
blood level and patient age), hyperthyroidism, as well as
hypersensitivity to iodine contrast media.
A total of 110 patients (59 men and 51 women, me-
dian age 65 [range 35–95 years]) underwent a 128-slice
chest-abdomen-pelvis CT examination: 55 using a fixed
tube potential of 120 kV/210 Ref.mAs, and 55 using au-
tomated attenuation-based tube potential selection that
selected the tube current based on the attenuationprofile of the topogram (CAREkV), adjusted to a prede-
fined image quality of 120 kV/210 Ref.mAs (Table 1).
Chest-abdomen-pelvis CT examinations were performed
for staging reasons in all patients. Patient populations
were paired regarding sex, age, body size and habitus.
The cancer-staging examinations were performed on a
broad range of cancer origins; the evaluated diseases are
listed in detail in Table 2.Automated attenuation-based kV selection
The automated tube potential selection CAREkV (Sie-
mens Healthcare, Forchheim, Germany) selects the
optimum tube potential for the diagnostic region to be
examined. Different settings can be adjusted during the
imaging protocol set up. Adjustment can be made by
using a 12-point scale tool as seen in Figure 1. This is
useful, because for a high-contrast situation such as vas-
cular imaging, lowering of the kV leads to higher ab-
sorption and higher attenuation values of the examined
vascular structures. After this ‘pre-set’ procedure, de-
pending on the body region and the anatomic structure
to be examined, the tube potential is selected by the pa-
tient’s topogram or scout. This is similar to the tube
current modulation already in use in nearly every radi-
ology department around the world (e.g., CareDose4D,
Siemens; Auto-mA, GE; DOM [DoseModulation], Phi-
lips; Real E.C., Toshiba).
The automatically selected kV remained stable
throughout the whole examination. After that, the corre-
sponding current, in mAs, was calculated. This was
selected in order to attain the user-given image quality
(e.g., 120 kV, 210 Ref.mAs). The user of the instrument
provided the machine with a preferred image quality,
which mostly depended on the standards in the particu-
lar radiology department. Then, the machine automatic-
ally selected the voltage and current, according to the
type of examination being performed (e.g., vascular,
bone, parenchymal, Figure 1). In our study, we used the
algorithm for parenchymal organs because the CT ex-
aminations were performed for cancer staging reasons
(Figure 1).






9 Non-small-cell lung carcinoma (NSCLC)
6 Oral cancer
6 Hepatocellular carcinoma
5 Renal cell carcinoma
4 Urothelial cell carcinoma
2 Pancreas Carcinoma
2 Cholangiocarcinoma











1 Merkel cell carcinoma
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CT examinations were performed on the experimental
group using a 128-slice CT machine (SOMATOM Def-
inition Flash, Siemens, Forchheim, Germany), using au-
tomated attenuation-based tube potential selection
(CAREkV). In the baseline group (conventional group)
without CAREkV, only CareDose4D and a fixed tube po-
tential of 120 kV were used.
Before the examination, the patients were enterally admin-
istered contrast media (Micropaque, Guerbet, Villepinte,Figure 1 Care-kV settings for the experimental group (group 1).France) and during the examination an intravenous contrast
material, containing 1 ml/kg of iodinated contrast material
(Ultravist 370, Bayer-Schering, Germany), followed by a sa-
line chaser of 40 mL.
Contrast material, as well as saline flush, was injected at
2 mL/s into an antecubital vein using a double-syringe
power injector (CT2, Medtron, Saarbruecken, Germany).
A fixed delay of 70 seconds post injection was used in
order to obtain venous contrast. All CT examinations
were performed in a cranio-caudal direction starting from
the upper thorax aperture down to the femoral ligaments,
at a collimation of 128 · 0.6 mm, pitch 1.2, and rotation
time of 0.5 seconds.
CT examinations were performed as follows:
Group 1 (experimental group) – 120 kV (using
CAREkV – where kV can be automatically adapted to
any of the following values: 80, 100, 120, and 140 kV),
210 Ref.mAs.
Group 2 (conventional group) – 120 kV (fixed), 210
Ref.mAs (using CareDose4D);
CT data reconstruction
For fast overviewing, images were reconstructed in 5-mm
slice thickness using a 5-mm increment. For further evalu-
ation, data were reconstructed with a slice thickness of
2 mm and increment of 1.5 mm using a medium-smooth
soft-tissue convolution kernel (B30f) for parenchymal ana-
lysis. A hard convolution kernel was used for the analysis
of bones and lungs (B70f). For detailed analysis and post-
processing, images were transferred to an external work-
station (SyngoVia, Multi-Modality Workplace, Siemens
Healthcare, Forchheim, Germany).
Radiation dose estimations
Effective mAs, kV, CTDIvol and DLP values were evalu-
ated using the patient protocol saved in our PACS system
after each examination was performed. However, CTDIvol
is only a measurement of scanner output and does not in-
clude information about patient size; therefore, additional
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(American Association of Physicists in Medicine) Report
204 [19]. For the calculation of the SSDE, patient dimen-
sions such as anteroposterior (AP) thickness at the mid-
line (measured from axial CT images) and lateral (LAT)
width were determined from the topogram (Tables 3 and 4).
Once the patient size is determined, f-size can be found
from the appropriate table in the AAPM Report 204 or
computed by use of a mathematical equation, as we did in
this study [19,20]. For each patient, AP and LAT dimen-
sions, as well as SSDE values, were calculated according to
the study by Christner et al. [20].
Image quality
Subjective image assessment was graded by two radiolo-
gists in consensus (with 2 and 5 years of experience in
whole body imaging), applying a five-point scoring system:
1 = excellent: excellent definition of tumour and/or metas-
tases, excellent delineation of the structures; 2 = good:
good definition of tumour and/or metastases, minimal
image noise; 3 = adequate: adequate definition of tumour
and/or metastases, slight impact of image noise, sufficient
for diagnosis; 4 = poor: poor definition of tumour and/or
metastases, low attenuation and difficult delineation of the
structures, increased image noise, diagnostic confidence
reduced; 5 = unacceptable/nondiagnostic. The most prob-
able reasons for reduced image quality were noted. Factors
reducing image quality (obesity, motion, metallic artefacts,
contrast medium flow-related, and contrast timing) were
recorded by the radiologists.
Objective image quality (e.g., attenuation, noise, CNR)
analysis was performed by one radiologist with 5 years
of experience in general radiology on a regular PACS
workstation (Centricity 4.2, General Electric Healthcare,
Munich, Germany). The measurements were performed
on several anatomic regions of the body (aorta at the





Age (years) 61 (20–82)
Body diameter: transverse (cm) 24.7 (15.1–40.9)
Body diameter: lateral (cm) 34.4 (28.1–47.8)
Scanning range (cm) 66.1 (50.8–76.4)
CTDIvol (mGy · cm) 10.5 (5.8–31.7)
SNR 26.4 (3.9 – 58.9)
CNR 17.7 (3.7 – 42.5)
SSDE 13.3 (9.7 – 28.6)lobe of the liver, right lobe of the liver, pancreas, spleen, kid-
neys, gluteus maximus muscle, bone and pre-sternally in
the air). For calculation of SNR, image noise (or back-
ground noise) was determined as the standard deviation
(SD) of air measured pre-sternally in front of the patient at
the level of the ascending aorta. Based on these measure-
ments, the signal-to-noise ratio (SNR) was determined ac-
cording to the following equation: SNR = attenuation/
background noise (Table 3). The CNR was defined as the
difference in signal intensity between the venous attenu-
ation in the vascular system (aorta) and the gluteus maxi-
mus muscle divided by the background noise. CNR was
calculated as follows: CNR= [(ROIaorta – ROImuscle)/
background noise]. To minimise bias from single measure-
ments, we calculated the average of four measurements for
each ROI.
Tumour and/or metastases were evaluated and mea-
sured using tumour diameters for objective evaluation
and, for subjective scoring, we evaluated whether the im-
aging modality might have affected the tumour staging.
To analyse the different habitus of each patient, the
antero-posterior and the lateral diameter of the abdo-
men were measured at the level of the celiac trunk, and
correlated to the kV that the dose modulation software
had chosen for the examination (Table 5).
Statistical analysis
Statistical analysis was performed using dedicated soft-
ware (Bias for Windows 9.14; Epsilon, Germany). Con-
tinuous variables were reported as median and range,
categorical variables as frequencies or percentages.
Radiation parameters and quantitative image parameters
(e.g. noise, attenuation) were tested using the Wilcoxon
Mann-Whitney U test as the data were nonparametric.
The relationship between patient diameter and automated
kV selection was analysed using the Spearman rank order
correlation test. The Chi-square (X2) test was used forGroup 2 p-Value:









32.2 (19 – 52.3) < 0.01
19.8 (12.1 – 34.1) 0.02
14.8 (9.4 – 28.9) 0.6
Table 4 Detailed overview of the different examination protocols
Patients Noise SSDE Effective
mAs
p-Value p-Value p-Value
Overall-Noise Overall-SSDE Overall- Eff. mAs
Group 1 vs. Group
2
Group 1 vs. Group
2





32 5.4 (4.0–8.2) 11.7 (9.7–14.5)
211 (141–353)








6 6.5 (4.7–12.4) 22.4 (20.9–28.6) 216 (204–322)
Group 2 Patients
120 kV
55 4.4 (3.1–6.7) 14.8 (9.4–28.9) 169 (89–534)
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significance was defined as a p-value above 0.05.
Results
Radiation dose estimation
Automated attenuation-based tube potential selection
resulted in a kV reduction of 120 to 100 kV in the ex-
perimental group, compared with the conventional
group in 32/55 (58.2%) patients; it was kept stable at
120 kV in 17/55 (30.9%) patients and increased to
140 kV in 6/55 (10.9%) patients.
The median DLP in the experimental group was 564
mGy · cm (390–871 mGy · cm) at 100 kV, 833 mGy · cm
(470–1235 mGy · cm) at 120 kV, and 1302 mGy · cm
(1157–2203 mGy · cm) at 140 kV. The analysis between 100
and 120 kV, as well as 140 kV, showed statistical significance
(Figure 2). The different values in median and range are
listed in Table 3.
The difference of DLP between the groups (CAREkV
vs. non-CAREkV) did not reach statistical significance
(p = 0.43) (Figure 2).
Comparing our radiation exposure data from the ex-
perimental and conventional groups using SSDE calcula-
tions, it was clear that there was no significant difference
(Table 3). However, the inter-group analysis showed that
there was a significant difference between the 100 kV



























330.8 (196.3–496.1) 241.9 (155the 140 kV group (p < 0.001) (Table 4). Between the
120 kV group and the 140 kV group there was no signifi-
cant difference in SSDE values (p = 0.1).
However, this inter-group analysis should be examined
with caution because there were only 6 patients in the
140 kV group. However, the results from the 100 kV group
show that 32 patients were exposed to significantly less ra-
diation, although the overall difference between the ex-
perimental and the conventional group did not reach
statistical significance (SSDE p-value = 0.6; Table 3).
Patient diameter was similar in the CAREkV group
and the conventional group, with a median lateral diam-
eter of 34.4 cm (range 28.1–47.8 cm) and 33.1 cm (range
19.6–49.6 cm), respectively (Table 1).
Image quality
Diagnostic image quality was obtained from all patients
(excellent: n = 42; good: n = 9; moderate: n = 4). The rea-
sons for moderate image quality (120 kV, n = 1; 100 kV,
n = 3) were, in all cases, due to difficulties in ruling out
parenchymal lesions, some because of image noise, and
some because of insufficiencies concerning the contrast.
Concerning image quality in the control group, it was
also rated as sufficient in all cases (excellent: n = 45;
good: n = 7; moderate: n = 3).
In summary, the image quality meant that all malig-




coefficient (rho) – lateral
diameter/DLP
Spearman correlation






Figure 2 Image quality comparison in parenchymal lesions. Pat. A: Patient suffering from malignant melanoma, liver metastasis - DLP 781
mGy · cm, without CarekV, Pat. B: Patient suffering from colorectal cancer, liver metastasis - DLP 485 mGy · cm, using CarekV.
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Criteria In Solid Tumours), without statistically significant
differences between the two groups (p = 0.5) (Figures 3
and 4) [21].
Discussion
Since the introduction of automated attenuation-based
tube potential selection, most of the literature about it
has been in the context of vascular imaging [18,22]. In
fact, only two studies have been published with a focus
on cancer patients [15,16].
Of course, this is not the only technique available for
lowering radiation exposure, and many new techniques
are in use today; automated tube-currents as well as au-
tomated tube- potential selection are only two of many
components that can be modified for reducing radiation
exposure. Other interesting techniques like iterative re-
construction are also in use and have been shown to
have additional potential in reducing radiation exposure
[6]. We wanted to evaluate whether this new technique
would be valuable for the imaging of cancer patients con-
cerning a non-stop (one-stop-shop) chest-abdominal-
pelvis CT examination in a daily clinical routine. We
evaluated a number of patients undergoing chest-abdomen-
pelvis CT for cancer staging.
In CT, a reduction in radiation dose by lowering the
tube potential results in a higher attenuation of the
iodinated contrast media. However, this does not always
have a positive effect, as the image noise will increaseFigure 3 Image quality comparison concering lymph-nodes. Pat. A: Pa
CarekV, Pat. B: Patient suffering from breast cancer - DLP 599 mGy · cm, usand soft-tissue contrast might be lost. To avoid this, the
tube current has to be adapted to the lower kV setting
(often to higher values). Therefore, the image noise will be
comparable, but the radiation exposure will be lower com-
pared to a 120 or 140 kV setting (Tables 3 and 4, Figure 2).
Winklehner et al. [18] evaluated automated attenuation-
based kV selection in 40 patients for CT angiography of
the aorta. In this study, an overall radiation dose reduction
of 25.1% was observed, while keeping the image quality
stable, when using a 120 kV protocol.
Eller et al. [15] evaluated automated attenuation-based
kV selection in 100 patients. They carried out an abdom-
inal CT examination for 52 of the patients, and a
thoraco-abdominal examination for 48 patients. All ex-
aminations using automated attenuation-based kV selec-
tion resulted in a radiation dose reduction of at least
11.4%; in detail, 13.2% in the abdominal CT group and
9.5% in the thoraco-abdominal group.
Gnannt et al. [16] assessed automatic attenuation-based
kV selection in 40 patients suffering from testicular cancer.
In this study, a CT scan of the chest was performed in a
mixed arterio-venous phase and the abdominal CT examin-
ation was carried out in the portal-venous phase of enhance-
ment. The overall dose reduction was 12% on average. In all
the studies mentioned above, there was no statistically sig-
nificant worsening of subjective image quality.
In the study by Eller et al. [15], there was a dose re-
duction of 9.5% in thoraco-abdominal CT examination.
Our data showed an overall dose reduction in 7.9% oftient suffering from follicular lymphoma - DLP 644 mGy · cm, without
ing CarekV.
Figure 4 DLP Values between the different groups. The above p-Value is between Group 1 and 2 in general. The lower p-Values is the analysis
of group 1 in the inter-group comparison.
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tient characteristics (e.g., body size and habitus). The tube
potential in our study switched more often to 140 kV com-
pared with the cited studies, and a tube potential of 80 kV
was not automatically chosen in any case (Tables 1 and 4).
In the imaging of vessels, it is possible to examine the
region of interest using a lower kV setting because of the
high-contrast situation attained by the arterial phase of
the contrast material. In clinical settings where paren-
chymal contrast is the object in question, for example,
when parenchymal liver lesions have to be ruled out, auto-
mated attenuation-based tube potential selection might
not lower the kV in the same aggressive manner as in the
imaging of vessels (Figure 1).
Applying the algorithm to our study population, the
overall radiation dose reduction was 7.9%. Comparing
the DLP and SSDE values in the experimental group, it
can be seen that the 100 kV patients received a signifi-
cantly lower dose compared with both other groups (31
patients received an examination at the 100 kV setting,
17 at 120 kV, and only 7 at 140 kV).In summary, these data indicate that in 31 patients, ra-
diation exposure was significantly reduced, whereas in
24 (17 + 7) patients, radiation exposure remained the
same or was not significantly increased. Keeping this in
mind, more than half of the examined patients could po-
tentially be examined with a lower radiation exposure in
daily clinical routine. In a busy radiology department,
sometimes it is difficult to adapt a CT examination
protocol in detail to each patient, therefore, software
such as CAREkV is able to improve the workflow and
reduce radiation exposure.
Limitations
Our study has some limitations. First, the overall num-
ber of patients was limited and further studies using a
larger population are required. Second, we did not rec-
ord the body mass index in detail, but added the patient
diameter to this study as an alternative. Third, CAREkV
is able to reduce the tube potential to as low as 80 kV.
This tube potential, however, was not selected by CAR-
EkV in our patient cohort. One cause for this might be
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diameter on average. Also, good parenchymal contrast is
needed in CT imaging for cancer staging.
Conclusion
In summary, we showed that attenuation-based tube po-
tential selection is a good tool for dose reduction in daily
clinical routine when ‘one-stop-shop’ cancer staging is
performed. It leads to a good and stable overall image
quality with only a mild increase in image noise. Radi-
ation exposure was decreased by 7.9% compared to our
former standard protocol using 120 kV.
Key points:
1. Automated attenuation-based tube potential selection
is easy to use and contributes to dose reduction efforts
in daily clinical routine.
2. When comparing 120 kV fixed tube potential using
automated tube current modulation and automated
attenuation-based tube potential selection, both lead
to the same image quality.
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